Welcome to our dedicated page for QHSLab SEC filings (Ticker: USAQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QHSLab, Inc. filings document a Nevada digital health issuer with Section 12(g) common stock traded under USAQ and no registered national exchange listing. Recent Form 8-K reports furnish Regulation FD press-release disclosures on Integrated Service Program growth, Q-Connect assessment launches, unaudited financial updates, fiscal results, and governance initiatives.
The company's material-event filings also record capital-structure transactions, including private placements of common stock and warrants, promissory note modifications, partial conversions, note repurchases, debt cancellation, and related unregistered sales of equity securities. These disclosures outline how QHSLab reports its financing activity, outstanding note obligations, common-stock issuance, and balance-sheet simplification alongside its digital health operating updates.
QHSLab, Inc. (USAQ) is reported to have 1,113,140 shares of its common stock beneficially owned by the Jeremy L. Smollar Irrevocable Trust dtd 2/13/2023 and by Jeremy L. Smollar, its sole trustee. This position represents approximately 7.4% of the outstanding common stock, based on 15,032,788 shares outstanding as of August 12, 2026.
The Trust holds the shares as record owner, and Jeremy L. Smollar, a U.S. citizen, has sole voting and sole dispositive power over all 1,113,140 shares. The Trust acquired these shares on August 26, 2026 by distribution from the Marvin Smollar Family Trust dtd 2/13/2023 under estate administration procedures, with no consideration paid. The reporting persons acknowledge that this Schedule 13G is being submitted on a late basis.
QHSLab, Inc. (USAQ) reports that The Justin B. Smollar Irrevocable Trust dtd 2/13/2023 and Justin B. Smollar, as sole trustee, have filed a Schedule 13G disclosing beneficial ownership of 1,113,140 shares of QHSLab common stock. This represents approximately 7.4% of the common stock, based on 15,032,788 shares outstanding as of August 12, 2026.
The trust holds all reported shares and Justin B. Smollar has sole voting and dispositive power over them. The trust acquired these shares on August 26, 2026 via distribution from the Marvin Smollar Family Trust, with no consideration paid. The reporting persons state they have no agreements with others regarding these shares and specifically disclaim being part of any group under Section 13(d).
QHSLab, Inc. (USAQ) received an amended Schedule 13D from the Marvin Smollar Family Trust reporting that it no longer beneficially owns any of the company’s common stock. The amendment also corrects a prior typographical error in the trust’s reported sole dispositive power.
On August 26, 2026, the trust distributed all 2,226,280 shares of QHSLab common stock in equal parts to two beneficiary irrevocable trusts, 1,113,140 shares each, as part of estate administration, with no consideration paid. Following this distribution, the trust reports 0 shares beneficially owned and 0.0% of the class, with no voting or dispositive power over any QHSLab shares.
QHSLab, Inc. (USAQ) reported an estate-related transfer by the Marvin Smollar Family Trust dtd 2/13/2023, a ten percent owner. On August 26, 2026, the trust disposed of 2,226,280 shares of common stock through distribution to two irrevocable trusts, with no consideration paid. Following the transaction, the trust reported holding 0 shares of QHSLab common stock.
QHSLab, Inc. (USAQ) reported higher revenues and improved margins for the three and six months ended June 30, 2026, while still posting a year-to-date loss and facing going concern uncertainty. Revenue was $847,490 for Q2 2026 and $1,576,175 for the first half of 2026, up from $605,446 and $1,250,865 in 2025, driven mainly by a more than doubling of Integrated Service Program (ISP) revenue. Gross margin rose to 69.6% in Q2 and 67.3% for the first half. Q2 delivered net income of $38,030, but the company recorded a $65,876 net loss for the six-month period and has an accumulated deficit of $3,969,427. Cash declined to $317,392 from $636,157 as the company used cash to fund operations and repay debt, eliminating loans and a convertible note, which sharply reduced interest expense. Management discloses substantial doubt about the company’s ability to continue as a going concern and reports that disclosure controls and procedures remain ineffective due to limited personnel and internal control weaknesses.
QHSLab, Inc. reported unaudited results for the three and six months ended June 30, 2026, showing strong growth in its Integrated Service Program (ISP). In Q2 2026, ISP revenue rose 86.4% to $491,399, while total revenue increased 40.1% to $847,490. Gross profit was $589,784 and gross margin expanded to 69.6%. Operating income increased to $45,245, and net income was $38,030, compared with a net loss of $52,958 a year earlier.
For the first half of 2026, total revenue grew 26.0% to $1,576,175, with ISP revenue up 103.2% to $865,900, representing roughly 55% of revenue. Gross profit reached $1,060,587 and gross margin improved to 67.3%. Interest expense declined 87.3% to $16,741 following retirement of substantially all legacy convertible debt, and the net loss narrowed to $65,876 from $132,567. Management emphasized the growing recurring, software-enabled revenue base and lower financing costs as evidence of improving operating leverage.
QHSLab, Inc. filed a current report describing its participation in the Planet MicroCap Las Vegas 2026 conference at the Bellagio, held on June 16-18, 2026. Company representatives will give a corporate presentation, furnished as Exhibit 99.1, and hold one-on-one meetings with various professional and high-net-worth investors.
The presentations will cover QHSLab’s business, strategy, products, market opportunity, growth initiatives, and financial performance, with the goal of increasing investor awareness. The information in Item 7.01, including Exhibit 99.1, is furnished under Regulation FD and is not deemed filed or incorporated into other securities law filings except by specific reference.
QHSLab also highlights that it uses its website and several social media channels, including Twitter/X, LinkedIn, Facebook, and Instagram, to share information that may be considered material, encouraging investors to follow these outlets for updates.
QHSLab, Inc. shared a shareholder update highlighting strong recent operating trends and growth initiatives. Unaudited revenue for April 2026 was approximately $325,889, up from $207,538 in April 2025, representing about 57% year-over-year growth, driven by increasing use of its digital medicine platform and integrated service program.
The Company introduced the QHS Practice Access Network (PAN), a nationwide independent representative program intended to accelerate adoption of its Q-Connect platform by leveraging existing healthcare relationships for warm introductions to physician practices. QHSLab also plans to present at the 2026 Planet MicroCap Showcase on June 16–18, 2026, to expand investor awareness of its digital health strategy.
QHSLab, Inc. reports Q1 2026 results with revenue of $728,685, up from $645,419 a year earlier, and a net loss of $103,906. Growth was driven by its Integrated Service Program, whose revenue more than doubled year over year.
Gross profit rose to $470,803, though gross margin slipped from 66.6% to 64.6% as newer service offerings carry higher delivery costs. Cash was $362,088 against current liabilities of $368,005, and operating activities used $200,242 in cash for the quarter.
The company ended the period with an accumulated deficit of $4,007,457 and explicitly states that these losses and its revenue level raise substantial doubt about its ability to continue as a going concern without improved cash flow or additional financing.
QHSLab, Inc. (USAQ) reported the beneficial ownership of a large shareholder through a Form 3 filing. The Marvin Smollar Family Trust dtd 2/13/2023 is identified as a ten percent owner with 2,226,280 shares of Common Stock held indirectly. This filing records an existing ownership position rather than a new purchase or sale.